Daptomycin Plasma and CSF Levels in Patients with Healthcare-Associated Meningitis

Area of Science:

• Pharmacokinetics and infectious disease research.
• Clinical pharmacology of antibiotics.

Background:

• Limited data exist on daptomycin's cerebrospinal fluid (CSF) penetration in healthcare-associated meningitis.
• Understanding drug distribution in the central nervous system is crucial for effective treatment.

Purpose of the Study:

• To characterize daptomycin pharmacokinetics in humans during a 7-day intravenous (IV) therapy.
• To evaluate daptomycin's penetration into CSF at a 10 mg/kg IV dose.

Main Methods:

• Prospective observational study of nine patients with healthcare-associated meningitis and external ventricular drainage.
• Daptomycin administered at 10 mg/kg for up to 7 days.
• Population pharmacokinetic (POP/PK) modeling using nonlinear mixed effects modeling.

Main Results:

• Significant inter-individual variability in plasma daptomycin exposure (AUC) was observed.
• Daptomycin exhibited minimal penetration into CSF, with a mean penetration of 0.45%.
• CSF concentration variability was lower than previously reported, with late Cmax occurrence.

Conclusions:

• Daptomycin demonstrates limited penetration into the central nervous system, even with prolonged IV therapy.
• The study suggests that daptomycin may not reach sufficient CSF concentrations for clinical efficacy in meningitis.
• Further research is warranted to explore daptomycin's potential in treating CNS infections.